Skip to main content

Fennec Pharmaceuticals Inc.

FENC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001211583

In the last 90 days, Fennec Pharmaceuticals Inc. insiders filed 0 open-market purchases and 6 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $175.1M in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Fennec Pharmaceuticals Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
6 filings
4 insiders, $1.51M in total
Insiders trading
4
Net value
−$1.51M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Fennec Pharmaceuticals Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Fennec Pharmaceuticals Inc.
NameTitleLast reported holdingLast filingFilings, past year
Brughera Marco MariaDirector0Sep 16, 20262
Raykov RostyOther: Former Director124,411Sep 1, 202618
Sayad Pierre SargisChief Medical Officer9,519Aug 31, 20266
Evans Terry LChief Commercial Officer21,519Aug 31, 20266
Cioffi Christiana MarieChief Strategy Officer24,644Aug 31, 20267
Hackman Jeffrey S.Chief Executive Officer66,302Aug 31, 20267
Andrade RobertCHIEF FINANCIAL OFFICER241,306Aug 31, 202618
Rallis Chris ADirector63,077Jun 10, 20263
Islam KhalidDirector213,825Jun 10, 20261
Cook Jodi ADirector–Jun 10, 20261
Southpoint Capital Advisors LP10% Owner2,744,741IndirectDec 29, 20254
Southpoint GP, LP10% Owner2,744,741IndirectDec 29, 20254
Southpoint Capital Advisors LLC10% Owner2,744,741IndirectDec 29, 20254
Southpoint GP, LLC10% Owner2,744,741IndirectDec 29, 20254
Clark John Smith II10% Owner2,744,741IndirectDec 29, 20254
Haigh AdrianCHIEF OPERATING OFFICER44,444May 21, 20240
Goel ShubhChief Commercial Officer–Dec 20, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Sep 16, 2026 (view filing)4:05 PM ETSep 151 dayBrughera Marco MariaDirectorSSale−15.5K$10.29−$160.0K−100.0%0 after10b5-1
Sep 1, 2026 (view filing)4:05 PM ETSep 1Same dayRaykov RostyOther: Former DirectorSSale−10.0K$12.11−$121.1K−7.4%124.4K after10b5-1
Aug 31, 2026 (view filing)8:15 PM ETAug 31Same daySayad Pierre SargisChief Medical OfficerSSale−12.0K$12.18−$146.2K−55.8%9.52K after
Aug 28, 2026 (view filing)5:42 PM ETAug 271 dayAndrade RobertCHIEF FINANCIAL OFFICERSSale−75.0K$11.78−$883.5K−25.6%217.7K after10b5-1
Aug 4, 2026 (view filing)4:05 PM ETAug 31 dayRaykov RostyOther: Former DirectorSSale−10.0K$9.58−$95.8K−7.1%131.6K after10b5-1
Jul 2, 2026 (view filing)4:05 PM ETJul 11 dayRaykov RostyOther: Former DirectorSSale−9.60K$10.41−$99.9K−6.5%138.9K after10b5-1
Jun 2, 2026 (view filing)Jun 11 dayRaykov RostyDirectorSSale−9.75K$9.62−$93.8K−7.0%130.1K after10b5-1
May 12, 2026 (view filing)May 111 dayRallis Chris ADirectorSSale−8.35K$7.04−$58.8K−11.7%63.1K after10b5-1
May 1, 2026 (view filing)May 1Same dayRaykov RostyDirectorSSale−10.8K$6.47−$69.8K−8.2%121.5K after10b5-1
Apr 2, 2026 (view filing)Apr 11 dayRaykov RostyDirectorSSale−10.9K$6.31−$69.1K−8.8%113.9K after10b5-1
Mar 3, 2026 (view filing)Mar 21 dayRaykov RostyDirectorSSale−10.1K$8.36−$84.3K−8.8%104.0K after10b5-1
Feb 2, 2026 (view filing)Feb 2Same dayRaykov RostyDirectorSSale−10.3K$7.76−$80.3K−9.5%98.5K after10b5-1
Jan 5, 2026 (view filing)Jan 23 daysRaykov RostyDirectorSSale−10.3K$7.60−$78.4K−10.5%88.0K after10b5-1
Dec 29, 2025 (view filing)4:34 PM ETDec 245 daysSouthpoint Capital Advisors LP and 4 others10% OwnerSSale−1.00M$7.50−$7.50M−26.7%2.74M after
Dec 5, 2025 (view filing)Dec 5Same dayRaykov RostyDirectorSSale−10.0K$7.54−$75.4K−11.4%77.5K after10b5-1
Nov 20, 2025 (view filing)4:07 PM ETNov 182 daysSouthpoint Capital Advisors LP and 4 others10% OwnerSSale−19.3K$8.79−$170.0K−0.5%3.74M after
Nov 17, 2025 (view filing)8:42 PM ETNov 14-173 daysSouthpoint Capital Advisors LP and 4 others10% OwnerSSale−246.0K$8.27−$2.04M−6.1%3.76M after2 lots
Nov 6, 2025 (view filing)Nov 51 dayRaykov RostyDirectorSSale−10.0K$8.10−$81.0K−10.8%82.3K after10b5-1
Oct 14, 2025 (view filing)Oct 104 daysRallis Chris ADirectorSSale−1.77K$9.24−$16.4K−3.0%57.1K after10b5-1
Oct 9, 2025 (view filing)5:31 PM ETOct 7-92 daysSouthpoint Capital Advisors LP and 4 others10% OwnerSSale−67.1K$9.48−$636.2K−1.6%4.01M after3 lots
Oct 6, 2025 (view filing)Oct 6Same dayRaykov RostyDirectorSSale−10.0K$9.78−$97.8K−10.8%82.5K after10b5-1
Sep 4, 2025 (view filing)Sep 4Same dayRaykov RostyDirectorSSale−10.0K$8.92−$89.2K−16.4%51.1K after10b5-1
Aug 5, 2025 (view filing)Aug 5Same dayRaykov RostyDirectorSSale−10.0K$8.09−$80.9K−15.2%55.9K after10b5-1
Jul 7, 2025 (view filing)Jul 7Same dayRallis Chris ADirectorSSale−1.12K$8.71−$9.75K−2.0%54.8K after10b5-1
Jul 7, 2025 (view filing)Jul 34 daysRaykov RostyDirectorSSale−10.0K$8.61−$86.1K−14.2%60.7K after10b5-1
Jun 6, 2025 (view filing)Jun 51 dayRaykov RostyDirectorSSale−10.0K$7.78−$77.8K−13.3%65.5K after10b5-1
May 19, 2025 (view filing)May 16-193 daysHackman Jeffrey S.Chief Executive OfficerPPurchase+15.0K$6.97+$104.6KNew position15.0K after2 lots
May 19, 2025 (view filing)May 163 daysRaykov RostyDirectorSSale−16.7K$6.78−$113.0K−19.2%70.3K after
May 5, 2025 (view filing)May 5Same dayRaykov RostyDirectorSSale−10.0K$6.31−$63.1K−15.7%53.6K after10b5-1
Apr 11, 2025 (view filing)Apr 11Same dayRallis Chris ADirectorSSale−1.41K$4.95−$6.97K−2.6%53.8K after10b5-1
Apr 4, 2025 (view filing)Apr 4Same dayRaykov RostyDirectorSSale−10.0K$5.25−$52.5K−14.1%61.2K after10b5-1
Mar 6, 2025 (view filing)Mar 51 dayRaykov RostyDirectorSSale−10.0K$6.79−$67.9K−12.7%68.7K after10b5-1
Feb 14, 2025 (view filing)Feb 14Same dayRallis Chris ADirectorSSale−1.19K$6.82−$8.09K−2.2%53.0K after10b5-1
Feb 5, 2025 (view filing)Feb 5Same dayRaykov RostyDirectorSSale−10.0K$6.66−$66.6K−11.6%76.3K after10b5-1
Jan 7, 2025 (view filing)Jan 61 dayRaykov RostyDirectorSSale−10.0K$6.08−$60.8K−10.7%83.9K after2 lots10b5-1
Dec 5, 2024 (view filing)Dec 5Same dayRaykov RostyDirectorSSale−796$6.04−$4.81K−1.2%66.4K after10b5-1
Dec 4, 2024 (view filing)Dec 31 dayRaykov RostyDirectorSSale−1.64K$6.13−$10.0K−2.4%67.2K after10b5-1
Dec 2, 2024 (view filing)Dec 2Same dayRallis Chris ADirectorSSale−6.41K$6.14−$39.4K−10.9%52.2K after10b5-1
Nov 4, 2024 (view filing)Nov 4Same dayRaykov RostyDirectorSSale−2.43K$4.31−$10.5K−3.5%66.4K after10b5-1
Oct 10, 2024 (view filing)Oct 82 daysRallis Chris ADirectorSSale−1.41K$4.53−$6.37K−2.8%48.6K after10b5-1
Oct 1, 2024 (view filing)Oct 1Same dayRaykov RostyDirectorSSale−2.43K$4.94−$12.0K−3.5%66.4K after
Sep 4, 2024 (view filing)Sep 4Same dayRaykov RostyDirectorSSale−2.43K$5.52−$13.4K−3.5%66.4K after
Aug 1, 2024 (view filing)Aug 1Same dayRaykov RostyCHIEF EXECUTIVE OFFICERSSale−2.43K$6.26−$15.2K−1.3%187.5K after
Jul 8, 2024 (view filing)Jul 53 daysRallis Chris ADirectorSSale−1.17K$6.03−$7.07K−2.5%46.5K after10b5-1
Jul 2, 2024 (view filing)Jul 2Same dayRaykov RostyCHIEF EXECUTIVE OFFICERSSale−2.43K$6.13−$14.9K−1.3%187.5K after10b5-1
Jun 3, 2024 (view filing)Jun 3Same dayRaykov RostyCHIEF EXECUTIVE OFFICERSSale−2.43K$6.76−$16.4K−1.3%187.5K after10b5-1
May 2, 2024 (view filing)May 11 dayRaykov RostyCHIEF EXECUTIVE OFFICERSSale−2.43K$9.11−$22.1K−1.3%187.5K after10b5-1
Apr 22, 2024 (view filing)Apr 19-223 daysHaigh AdrianCHIEF OPERATING OFFICERSSale−44.4K$9.33−$414.7K−100.0%0 after2 lots10b5-1
Apr 15, 2024 (view filing)Apr 15Same dayRallis Chris ADirectorSSale−800$10.45−$8.36K−1.8%44.4K after10b5-1
Apr 5, 2024 (view filing)Apr 4-51 dayRaykov RostyCHIEF EXECUTIVE OFFICERSSale−88.6K$10.82−$958.5K−32.1%187.5K after3 lots10b5-1